ArticleBlood2011

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

Lapo Alinari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.